I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Disclaimer : The Competition DG makes the information provided by the notifying parties in section 4 of Short Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.
This notification concerns the proposed acquisition of joint control by Novo Holdings A/S over the Target within the meaning of Article 3(1), point (b) and Article 3(4) of the Merger Regulation (the “Transaction”). The Target is currently solely controlled KKR & Co. (“KKR & Co.” and together with its subsidiaries, “KKR”) (via special purpose vehicles, Musk Prosperity Holdings Pte. Ltd. and Musk Investments Pte. Ltd.). Post-Transaction, the Target will be jointly controlled by Novo Holdings and KKR (via a continuation vehicle controlled by KKR).
The Transaction will be facilitated by way of subscription of shares in the Target.
(a) Novo Holdings is a holding and investment company headquartered and incorporated in Copenhagen, Denmark. It is responsible for the management of the assets of Novo Nordisk Foundation, through strategic investments in the life sciences, planetary health and related areas and through investments of a financial and venture capital nature in a broad portfolio of companies.
(b) KKR & Co. is incorporated in Delaware, USA. KKR is a global investment firm that offers alternative asset management as well as capital markets and insurance solutions.
(c) The Target is incorporated in China and is active in the development and production of spawn (propagated genetics) for edible mushrooms.
Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË - Tel. +32 22991111